AbbVie · 2 weeks ago
2026 Biologics Analytical Research & Development Intern (PhD)
South San Francisco, CA
Internship
Onsite
Intern
$59K/yr - $100K/yr
Start in 2026 SummerAbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The Biologics Analytical Research & Development Intern will support the Advanced Instrumentation and Mass Spectrometry analytical team, focusing on developing MS methodologies for biopharmaceuticals.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Develop a new hyphenated MS / automation / bioinformatics method applicable to biopharmaceutical drugs
Present development results and findings at an internal conference at the conclusion of the internship
Qualification
Required
Currently enrolled in university, pursuing a PhD in Chemistry, Biochemistry, Analytical Chemistry, Chemical Engineering or other related field
Must be enrolled in university for at least one semester following the internship
Scientifically curious with strong communication, collaboration, and adaptability skills
Preferred
Expected graduation date between December 2026 – June 2027
Exposure to protein separations, structure elucidation, proteomics
Exposure to LCMS software and/or strong interest to learn more
Experience with Liquid Chromatography (HPLC, UPLC, etc.)
Experience with lab automation and data analysis tools (R, Python, etc.)
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
Founded in 2013
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase